On Jan 14, 2019 Daxor Corporation (NYSEAMERICAN:DXR) Sellers Increased Their Shorts By 42.15%

Daxor Corporation (NYSEAMERICAN:DXR) Corporate Logo

Big Money Sentiment decreased to 0.2 in 2018 Q3. It has change of 0.80, from 2018Q2’s 1. The ratio fall due to Daxor Corporation positioning: 3 sold and 2 reduced. 1 funds acquired positions and 0 increased positions. Investors holded 62,583 in 2018Q2 but now own 49,584 shares or 20.77% less.
Renaissance Technologies Ltd Liability invested in 0% or 33,100 shs. Citadel Advsrs holds 13,545 shs. Moreover, Blackrock has 0% invested in Daxor Corporation (NYSEAMERICAN:DXR) for 131 shs. Panagora Asset Mngmt Inc invested 0% in Daxor Corporation (NYSEAMERICAN:DXR).

Daxor Corporation registered $18,550 net activity with 1 insider purchase and 0 sales since November 7, 2018.

Change of 42.15% for Daxor Corporation (NYSEAMERICAN:DXR)’s shares shorted was noted. In January was published DXR’s total 233,700 shares shorted by FINRA. That’s 42.15% up from 164,400 shares. Daxor Corporation (NYSEAMERICAN:DXR) has 357,900 shares average volume. It’ll cost 1 days for DXR to restore its former position. Float short on Daxor Corporation is 29.61%.

DXR touched $13.95 during the last trading session after $0.95 change.Currently Daxor Corporation is uptrending after 32.00% change in last January 14, 2018. DXR has 150,520 shares volume. The stock outperformed the S&P 500 by 32.00%.

Daxor Corporation, a medical device company, provides biotechnology and cryobanking services in the United States.The firm is worth $52.02 million. The firm offers BVA-100 Blood Volume Analyzer, an instrument that measures blood volume in human body.Last it reported negative earnings. BVA-100 Blood Volume Analyzer is used to diagnose and treat patients in various medical and surgical conditions, including congestive heart failure, critical care medicine and intensive care unit medicine, hypertension, syncope, pre-operative blood screening for hidden anemia, anemia in cancer patients, kidney failure, and hyponatremia.

Daxor Corporation (NYSEAMERICAN:DXR) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.